998TiP GUARDIAN-101: A first in human, tumor agnostic phase I study evaluating safety and preliminary antitumor activity of CLSP-1025, a first in class, HLA-directed T cell engager (TCE) for advanced solid tumors harboring the p53 R175H mutation.
Saved in:
| Title: | 998TiP GUARDIAN-101: A first in human, tumor agnostic phase I study evaluating safety and preliminary antitumor activity of CLSP-1025, a first in class, HLA-directed T cell engager (TCE) for advanced solid tumors harboring the p53 R175H mutation. |
|---|---|
| Authors: | Subbiah, V.1 (AUTHOR), Bashir, B.2 (AUTHOR), El-Khoueiry, A.B.3 (AUTHOR), Punekar, S.4 (AUTHOR), Khawaja, M.R.5 (AUTHOR), Gutierrez, M.6 (AUTHOR), Olszanski, A.J.7 (AUTHOR), Bilusic, M.8 (AUTHOR), Arnold, S.M.9 (AUTHOR), Scott, A.J.10 (AUTHOR), Berlin, J.D.11 (AUTHOR), Oh, D.12 (AUTHOR), Schoenfeld, A.13 (AUTHOR), Zhen, D.B.14 (AUTHOR), Liao, C-Y.A.15 (AUTHOR), Shepherd, J.16 (AUTHOR), McEachern, K.17 (AUTHOR), Harshman, L.C.16 (AUTHOR), Luke, J.J.18 (AUTHOR), Yap, T.A.19 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS652-S653. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419380 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 998TiP GUARDIAN-101: A first in human, tumor agnostic phase I study evaluating safety and preliminary antitumor activity of CLSP-1025, a first in class, HLA-directed T cell engager (TCE) for advanced solid tumors harboring the p53 R175H mutation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Subbiah%2C+V%2E%22">Subbiah, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bashir%2C+B%2E%22">Bashir, B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22El-Khoueiry%2C+A%2EB%2E%22">El-Khoueiry, A.B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Punekar%2C+S%2E%22">Punekar, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khawaja%2C+M%2ER%2E%22">Khawaja, M.R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gutierrez%2C+M%2E%22">Gutierrez, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Olszanski%2C+A%2EJ%2E%22">Olszanski, A.J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bilusic%2C+M%2E%22">Bilusic, M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arnold%2C+S%2EM%2E%22">Arnold, S.M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scott%2C+A%2EJ%2E%22">Scott, A.J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berlin%2C+J%2ED%2E%22">Berlin, J.D.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oh%2C+D%2E%22">Oh, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schoenfeld%2C+A%2E%22">Schoenfeld, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhen%2C+D%2EB%2E%22">Zhen, D.B.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liao%2C+C-Y%2EA%2E%22">Liao, C-Y.A.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shepherd%2C+J%2E%22">Shepherd, J.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McEachern%2C+K%2E%22">McEachern, K.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harshman%2C+L%2EC%2E%22">Harshman, L.C.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luke%2C+J%2EJ%2E%22">Luke, J.J.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yap%2C+T%2EA%2E%22">Yap, T.A.</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS652-S653. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419380 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.1567 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S652 Titles: – TitleFull: 998TiP GUARDIAN-101: A first in human, tumor agnostic phase I study evaluating safety and preliminary antitumor activity of CLSP-1025, a first in class, HLA-directed T cell engager (TCE) for advanced solid tumors harboring the p53 R175H mutation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Subbiah, V. – PersonEntity: Name: NameFull: Bashir, B. – PersonEntity: Name: NameFull: El-Khoueiry, A.B. – PersonEntity: Name: NameFull: Punekar, S. – PersonEntity: Name: NameFull: Khawaja, M.R. – PersonEntity: Name: NameFull: Gutierrez, M. – PersonEntity: Name: NameFull: Olszanski, A.J. – PersonEntity: Name: NameFull: Bilusic, M. – PersonEntity: Name: NameFull: Arnold, S.M. – PersonEntity: Name: NameFull: Scott, A.J. – PersonEntity: Name: NameFull: Berlin, J.D. – PersonEntity: Name: NameFull: Oh, D. – PersonEntity: Name: NameFull: Schoenfeld, A. – PersonEntity: Name: NameFull: Zhen, D.B. – PersonEntity: Name: NameFull: Liao, C-Y.A. – PersonEntity: Name: NameFull: Shepherd, J. – PersonEntity: Name: NameFull: McEachern, K. – PersonEntity: Name: NameFull: Harshman, L.C. – PersonEntity: Name: NameFull: Luke, J.J. – PersonEntity: Name: NameFull: Yap, T.A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
